XML 25 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]      
Revenue $ 267,116 $ 186,892 $ 210,430
Costs and expenses:      
Partner Share and other third-party costs 141,273 109,308 118,080
Delivery costs 22,503 14,310 12,893
Sales and marketing expense 65,996 45,307 43,828
Research and development expense 38,104 17,532 11,699
General and administration expense 66,222 46,532 36,720
Acquisition and integration costs 24,372 0 0
Change in fair value of contingent consideration 1,374 0 0
Depreciation and amortization expense 29,871 7,826 4,535
Total costs and expenses 389,715 240,815 227,755
Operating loss (122,599) (53,923) (17,325)
Other Income and Expenses [Abstract]      
Interest expense, net (12,563) (3,048) (548)
Other Nonoperating Income (Expense) (1,267) 1,549 729
Nonoperating Income (Expense), Total (13,830) (1,499) 181
Loss before income taxes (136,429) (55,422) (17,144)
Income tax benefit 7,864 0 0
Net loss (128,565) (55,422) (17,144)
Net loss attributable to common stockholders $ (128,565) $ (55,422) $ (17,144)
Net loss per share attributable to common stockholders, basic and diluted (in USD per share) $ (3.99) $ (2.04) $ (0.72)
Weighted-average common shares outstanding, basic and diluted (in shares) 32,202 27,213 23,746